flurbiprofen has been researched along with guaifenesin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brooks, CD; Metzler, C; Nelson, AL | 1 |
Holm, L; Perry, MA; Phillipson, M | 1 |
1 review(s) available for flurbiprofen and guaifenesin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for flurbiprofen and guaifenesin
Article | Year |
---|---|
Effect of flurbiprofen, a cyclooxygenase inhibiting drug, on induced allergic rhinitis.
Topics: Adult; Analysis of Variance; Female; Flurbiprofen; Humans; Middle Aged; Mucus; Nasal Provocation Tests; Propionates; Pruritus; Rhinitis, Allergic, Seasonal; Skin Tests; Sneezing | 1984 |
2 other study(ies) available for flurbiprofen and guaifenesin
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
NO-flurbiprofen maintains duodenal blood flow, enhances mucus secretion contributing to lower mucosal injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Duodenum; Flurbiprofen; Intestinal Mucosa; Male; Mucus; Nitric Oxide; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasodilator Agents | 2002 |